Duration of Terbinafine Therapy
For fingernail infections, take terbinafine 250 mg daily for 6 weeks; for toenail infections, take 250 mg daily for 12 weeks (or up to 16 weeks for severe cases). 1, 2
Treatment Duration by Site
Fingernail Onychomycosis
- 6 weeks of continuous daily therapy at 250 mg 1, 2
- This shorter duration is sufficient due to faster nail growth rate
Toenail Onychomycosis
- 12 weeks is the standard licensed duration 1, 2
- 12-16 weeks may be used for more extensive disease 1
- The longer duration accounts for slower toenail growth and deeper fungal penetration
Skin Infections (Tinea Corporis/Pedis)
- 2 weeks for most superficial skin infections 3, 4
- Moccasin-type tinea pedis may require longer courses
Post-Treatment Monitoring
Re-evaluate patients 3-6 months after treatment initiation 1. This timing is critical because:
- Terbinafine persists in nails for up to 6 months after stopping treatment 1
- Clinical improvement continues during this post-treatment period
- Further treatment should be given if disease persists at re-evaluation 1
Important Clinical Considerations
Why These Specific Durations Work
The British Association of Dermatologists guidelines emphasize that terbinafine's pharmacokinetics allow for these relatively short treatment courses 1. The drug:
- Reaches nail tissue within 1 week of starting therapy 1, 5
- Persists in nails for considerable periods after plasma elimination 1
- Maintains therapeutic concentrations for at least 30 weeks post-treatment 5
Monitoring Requirements
Baseline liver function tests and complete blood count are mandatory before starting therapy, particularly in patients with 1:
- History of heavy alcohol consumption
- Hepatitis or liver disease
- Haematological abnormalities
- Concomitant hepatotoxic drug use
Common Pitfalls to Avoid
Don't stop early: Patients may see improvement before completing the full course, but stopping prematurely increases relapse risk 1
Don't extend unnecessarily beyond 16 weeks for initial treatment: The standard durations are evidence-based; longer initial courses don't significantly improve outcomes 6
Don't forget the re-evaluation window: Assessing response at 3-6 months is when you can truly determine mycological and clinical cure 1
Watch for treatment failure indicators: If no improvement by 3-6 months, consider:
Special Populations
Candida onychomycosis: Terbinafine is less effective and requires much longer treatment - up to 48 weeks for adequate cure rates 1. Itraconazole is preferred first-line for Candida infections.
Pediatric patients: Terbinafine is not licensed for pediatric onychomycosis, though it is approved for tinea capitis in children 1
Efficacy Data Supporting These Durations
The landmark L.I.ON study demonstrated that 16 weeks of continuous terbinafine achieved 81% mycological cure at 72 weeks follow-up, with only 23% relapse rate at 5 years 1. This substantially outperformed itraconazole (49% cure, 53% relapse) and established terbinafine as first-line therapy 1.
For toenail infections specifically, 12-week treatment achieved 82% complete cure at 24 weeks and maintained 71% cure at 48 weeks in randomized trials 6. The 6-week regimen showed lower sustained cure (40% at 48 weeks), confirming 12 weeks as optimal for toenails 6.